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When lesions are subtle or questionably related to treat-3. Peer review of toxicology studies.
The advantages given for "blind" pathology are the maintenance of the integrity of the control group, prevention of bias, and protection of the pathologist from charges of bias. There are serious disadvantages to such a technique, both scientific and economic, which have been described in detail in a number of papers. Perusal of the references below indicates pathologists are virtually unanimous in opposition to conducting "blind" pathologic studies. Some of the viewpoints expressed will be discussed here.
The most serious objection to "blind" pathology is the loss of the knowledge about lesions which may exist in the concurrent control animals. The pathologist uses the concurrent control to set baseline values for what is "normal" or expected in untreated animals of the same species, strain, sex, and age under comparable environmental conditions among treated and untreated animals. This knowledge is essential in detecting subtle toxic changes. The pathologist must be able to compare groups of treated and control animals to help define such changes. It allows the pathologist to concentrate on detection and definition of those lesions which differ from the baseline established by examination of controls. It also allows the pathologist to identify disease processes and to use a single diagnosis rather than a plethora of diagnoses describing each component of a complex process. Multiple diagnoses for a single disease can obscure treatmentrelated effects. Since many lesions attributed to administration of a substance may also be seen in controls, grading the severity of such lesions is important. Criteria for grading a lesion are based on a knowledge of the spectrum of the severity seen in the study. These criteria can be defined much more rapidly and accurately with knowledge of treatment groups and thus can be used in the initial evaluation. In a "blind" study, all slides would be evaluated before the criteria studies.
ment.
have been set. This would then require re-evaluation of all slides of the affected organ simply to grade the lesions, incurring additional time and expense.
In order to make the most accurate analysis of lesions, the pathologist must have all the available information, such as clinical observations, clinical chemistries, hematology, observations at necropsy as well as findings in other related studies. This enables the pathologist to look carefully for correlations to these observations. Rather than introducing bias, this process will cause the pathologist to assess more accurately any effects related to such supplemental data. The purpose of toxicology studies is to determine whether or not a substance is capable of causing disease. Anything which will increase the sensitivity of the test and enhance the possibility of detecting such an effect is advantageous. Any possible bias introduced can be corrected by the use of "blind" evaluation after identification of specific endpoints. This second review can be done either by the original pathologist or by peer review to assure that the lesions are specifically related to treatment. This procedure is currently followed by most pathologists. Initial examination by "blind" method introduces other possible complications such as:
1. The probability of error in encoding and decoding. 2. Increased time required to conduct study. 3. Difficulties in tracking animals through an entire study (i.e., auditing a study).
In the initial evaluation of a toxicology study, it is important that the pathologist have access to all of the information available for each animal, including treatment. The quality of the initial evaluation of a toxicology study depends on the expertise, training, experience, and dedication of the pathologist. The issue of bias in the pathologic evaluation of toxicology studies can best be resolved by a two-step process consisting of an original review with full knowledge of the animal's history and a second review of identified endpoints either by the original pathologist in a "blind" fashion and/ or by peer review.
The Council of the American College of Veterinary Pathologists strongly urges consideration of the above by those who may wish to change current methods of evaluating pathologic studies.
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